Predictors of re-participation in faecal occult blood test-based screening for colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 5989-5994

  Cole, Stephen R ^a,b   Gregory, Tess ^b   Whibley, Alex ^a,b   Ward, Paul ^b   Turnbull, Deborah ^c   Wilson, Carlene ^a,d   Flight, Ingrid ^e   Esterman, Adrian ^f   Young, Graeme P ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

^e CSIRO   (Australia)

^f NONE

Author keywords

Colorectal cancer; Faecal occult blood test; Prevention; Re screening; Screening program; South Australia

Indexed keywords

AUSTRALIA; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; HUMAN; MASS SCREENING; MULTIVARIATE ANALYSIS; OCCULT BLOOD;

AUSTRALIA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; MULTIVARIATE ANALYSIS; OCCULT BLOOD;

EID: 84877042854     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.5989     Document Type: Article

References (31)

1. Australian Institute of Health and Welfare:AIHW, 2006, Information Paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA), Australian Bureau of Statistics
2. Australian Institute of Health and Welfare and Australian Government Department of Health and Ageing, 2008, 2007, National Bowel Cancer Screening Program Monitoring Report, Cancer series no. 40. Cat. no. CAN 35, AIHW, Canberra
3. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee, 2005, The Australian Bowel Cancer Screening Pilot Program: Analysis of routinely collected screening data November 2004, Screening Monograph No 5, Commonwealth of Australia
4. Cole SR, Young GP, Esterman A, Cadd B, Morcom J (2003). A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen, 10, 117-22.
5. Doggrell SA (2010). Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging, 27, 239-54.
6. von Euler-Chelpin M, Brasso K, Lynge E (2010). Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health, 32, 395-405.
7. Faivre J, Tazi M, Mrini TE et al (1999). Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer, 79, 680-3.
8. Farrands PA, Hardcastle JD, Chamberlain J, Moss S (1984). Factors affecting compliance with screening for colorectal cancer. Community Med, 6, 12-9.
9. Fenton JJ, Elmore JG, Buist DSM, et al (2010). Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med, 8, 397-401.
10. Gili M, Roca M, Ferrer V, Obrador A, Cabeza E (2006). Psychosocial factors associated with the adherence to a colorectal cancer screening program. Cancer Detect Prev, 30, 354-60.
11. Hart AR, Barone TL, Gay SP et al (1997). The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. J Epidemiol Community Health, 51, 187-91.
12. Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7.
13. Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E (2007). Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews, 1, 1216.
14. Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM (2010). Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting. J Gastroenterol Hepatol, 25, 1661-7.
15. Jansen JH (1984). Participation in the first and second round of a mass-screening for colorectal cancer. Soc Sci Med, 18, 633-6.
16. Jorgenson OD, Kronborg O, Fenger C (2002). A randomised study of screening for colorectal cancer using fecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut, 50, 29-32.
17. Kewenter J, Bjork S, Haglind E, et al (1988). Screening and rescreening for colorectal cancer-A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer, 62, 645-51.
18. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O (1989). Repeated screening for colorectal cancer with a faecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastro, 24, 599-606.
19. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard 0 (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71.
20. Lindholm E, Brevinge H, Haglind E (2008). Survival benefit in a randomized clinical trial of faecal occult blood sceening for colorectal cancer. Br J Surg, 95, 1029-36.
21. Mandel JS, Bond JH, Church TR, et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med, 328, 1365-71.
22. Mandel JS, Church TR, Ederer F, Bond JH (1999). Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst, 91, 434-7.
23. Neilson AR, Whynes DK (1995). Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med, 41, 365-74.
24. Sewitch MJ, Fournier C, Ciampi A, Dyachenko A (2007). Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterology, 7, 39.
25. Steele RJ, McClements PL, Libby G, et al (2009). Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut, 58, 530-5.
26. Thomas W, White C, Mah J et al (1995). Longitudinal compliance with annual screening for fecal occult blood. Am J Epidemiol, 142, 176-82.
27. UK Colorectal Cancer Screening Pilot Group (2004). Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ, 329,133-5.
28. Young GP (2009). Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol, 24, 33-42.
29. Vernon S (1997). Participation in colorectal cancer screening: a review. J Natl Cancer Inst, 89, 1406-22.
30. Weller D, Coleman D, Robertson R, et al (2007). The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer, 97, 1601-5.
31. Ward PR, Javanparast S, Cole S, et al (2011). The equity of colorectal cancer screening: a cross-sectional analysis of the National Bowel Cancer Screening Program data for South Australia. Aust N Z J Public Health, 35, 61-5.